Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Rankning i aktier #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Aktiekurs
$6.02
Senast synkroniserad: 2026-08-27
Marknadsvärde
$1.93B
Förändring (1 dag)
0.00%
Förändring (1 år)
112.72%
Land
US
Handel Taysha Gene Therapies, Inc. (TSHA)

Kategori

Aktiekurshistorik för Taysha Gene Therapies, Inc. (TSHA)
Högsta slutkurs: $6.22 den 2026-08-01

Lägsta slutkurs: $23.52 den 2020-09-01
Aktiekurshistorik för Taysha Gene Therapies, Inc. från 2020 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -5.89%
2025 151.61%
2024 28.42%
2023 -21.84%
2022 -83.88%
2021 -42.11%
2020 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH